Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease
US7067515B2 · kind B2 · utility
16Cited by
50References
64Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 6, 2002 |
| Grant date | Jun 27, 2006 |
| Priority date | — |
| Expiry date | Jun 6, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compounds of Formula I:where in W isThese compounds may be in the form of pharmaceutical salts or compositions, racemic mixtures, or pure enantiomers thereof. The compounds of Formula I are useful to treat diseases or conditions in which α7 is known to be involved.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.